FN1 and hepatocellular carcinoma: Although this study employed only one cell line, results showed that the IC50 for lenvatinib increased under hypoxia and that HCC cells exhibited a lenvatinib resistance phenotype under hypoxia conditions that could be mediated by changes observed in the extracellular matrix, mainly associated to fibronectin [57].